Step-by-step: the CD8 T cell journey in leishmaniasis
Open Access
- 8 October 2025
- journal article
- review article
- Published by American Society for Microbiology in mBio
- Vol. 16 (10) , e0353723
Abstract
Leishmaniasis is a group of vector-borne diseases caused by protozoan parasites of the genus Leishmania that affect millions of people across nearly 100 countries. Clinical presentations range from self-resolving cutaneous ulcers to life-threatening visceral disease, depending on the infecting species and host immune response. While CD4 T cells have long been recognized as central to parasite control, CD8 T cells also play an important role in disease. In this mini-review, we explore the many steps involved in CD8 T cell responses in leishmaniasis, with a focus on antigen recognition, recruitment, effector function, memory development, and dysfunction. Drawing on both murine models and human studies, we highlight the duality of CD8 T cells, which can contribute to protection but also drive immune-mediated tissue damage. Recent advances in transcriptomics, in vivo modeling, and immunophenotyping have begun to clarify the conditions under which CD8 T cells support vs hinder host defense. Despite this progress, critical questions remain, and continued investigation into the heterogeneity and regulation of CD8 T cells in leishmaniasis promises not only to deepen our understanding of host-pathogen interactions but also to guide the development of targeted immunotherapies and vaccines.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI162711)
- National Institute of Allergy and Infectious Diseases (AI165391)
This publication has 98 references indexed in Scilit:
- Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapyEuropean Journal of Immunology, 2024
- Leishmania donovani induces CD300a expression to dampen effector properties of CD11c+ dendritic and antigen activated CD8+ T cellsActa Tropica, 2023
- SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade ImmunityCell Reports, 2020
- Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous LeishmaniasisJournal of Investigative Dermatology, 2020
- NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in VitiligoJournal of Investigative Dermatology, 2020
- Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin InflammationCell Host & Microbe, 2017
- The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite controlPurinergic Signalling, 2016
- Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17‐related cytokinesEuropean Journal of Immunology, 2010
- A Role for the Transcriptional Repressor Blimp-1 in CD8+ T Cell Exhaustion during Chronic Viral InfectionImmunity, 2009
- CXCR3–/– mice mount an efficient Th1 response but fail to control Leishmania major infectionEuropean Journal of Immunology, 2005